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Sign-Tracking Totals

• Sign-tracking: The tendency of an organism to engage with a
conditioned stimulus (CS) signaling a forthcoming appetitive
unconditioned stimulus (US). Contrasted with goal-tracking
(approaching location of US, if separate from the CS).
• Sign-tracking may be comparable to drug addicts impulsively
approaching/interacting with drug-related cues, derailing
rehabilitation efforts. Our lab is exploring the effects of drugs
that could be used to reduce sign-tracking and thus aid in
rehabilitation.
• Bupropion, also known as Wellbutrin, is a norepinephrine—
dopamine reuptake inhibitor (NDRI) used to treat major
depressive disorder and has been found to aid in smoking
cessation. If successful in reducing sign-tracking, bupropion
could be used to aid in drug addiction treatment generally.
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Introduction:
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Methods:
n= 48 male Sprague-Dawley rats
Operant chambers equipped with retractable levers and food
receptacles (with infrared head detectors) were used.
3 Phases:
Habituation: 20 Min/day for 2 days
Introduced to banana pellets on day 2
Then, 48-hour break
Training: 1 Session/day for 5 total days
25 trials in each session
Lever presented for 8 seconds, Banana pellets drop in
food receptacle. Sign-tracking = interaction with lever
during trial. (Note = lever-pressing is not reinforced;
rather it is used as a measure of sign-tracking.) Goaltracking = head entering food receptacle during trial.
We then divided the subjects into their respective
behavioral phenotypes (sign-trackers, goal-trackers,
intermediates based on criteria of Meyer et al., 2012)
Drug Trials: 1 session per day/ 3 total days 48 hours apart
Saline, 20mg/kg (LOW), 40mg/kg (MED), 60mg/kg
(HIGH)
Drug administered 30 Min before trial.
Hypothesis: Bupropion will reduce sign-tracking.
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Discussion:
We confirmed our hypothesis that sign-tracking would be reduced
under bupropion. We also found that goal-tracking was increased,
suggesting that the two responses may have been competing with
each other. In fact, we found effects on goal-tracking using both the
medium and large doses. Since goal-tracking often reflects frontal
lobe engagement, use of bupropion may contribute to inhibition of
impulsive behavior. Our results suggest that bupropion may be an
effective adjunct medication for patients attempting rehabilitation.
Human trials would be necessary to see if we get the same effect as
this work has just been done with animals.

Figure 1 represents sign-tracking as a function of dose and
behavioral phenotype. A mixed model ANOVA using dose
and behavioral phenotype as factors found a significant
effect of sign-tracking between dose F(3,132)=9.47, p<.001,
partial h2 =0.177 and dose by Behavioral Phenotype
F(6,132)=3.87, p=0.001.
Post hoc testing using Tukey’s HSD found a significant
difference in sign-trackers between saline and the 60 mg
dose, t(44)=4.786, p=.001, between 20mg and 60mg dose
t(44)=6.985, p<.001, and between the 40mg and 60mg dose,
t(44)=4.204, p=.006.
Figure 2 represents goal-tracking as a function of dose and
behavioral phenotype. A mixed model ANOVA using dose
and behavioral phenotype as factors found a significant
effect of dose on goal-tracking F(2.01, 90.24)= 14.95,
p<0.001; We did not find a significant dose by behavioral
phenotype interaction, F(4.01, 90.24)=1.32,p=0.27. Lastly,
We found a significant effect of behavioral phenotype,
F(2,45)=43.5, p<0.001.
Post hoc tests using Tukey’s HSD found a significant
difference between Saline and 40mg/kg , t(45)= -4.09,
p<0.001, and a significant difference between saline and
60mg/kg, t(45)= -4.72, p<0.001. We also found a significant
difference between 20 mg/kg and 40 mg/kg, t(45)= -3.39,
p=0.008, as significant difference between 20 mg/kg and
60mg/kg , t(45)= -4.18, p<0.001, however, no other
significant effects were found.
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